Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis.
Justin J KuhlmanMuhamad Alhaj MoustafaAlexander J TunDavid M MenkeHan W TunLiuyan JiangPublished in: Clinical case reports (2021)
EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.